|
1
|
Ginsburg O, Bray F, Coleman MP, Vanderpuye
V, Eniu A, Kotha SR, Sarker M, Huong TT, Allemani C, Dvaladze A, et
al: The global burden of women's cancers: A grand challenge in
global health. Lancet. 389:847–860. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Denny L, de Sanjose S, Mutebi M, Anderson
BO, Kim J, Jeronimo J, Herrero R, Yeates K, Ginsburg O and
Sankaranarayanan R: Interventions to close the divide for women
with breast and cervical cancer between low-income and
middle-income countries and high-income countries. Lancet.
389:861–870. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan L, Strasser-Weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in china. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in china,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cella D and Fallowfield LJ: Recognition
and management of treatment-related side effects for breast cancer
patients receiving adjuvant endocrine therapy. Breast Cancer Res
Treat. 107:167–180. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taylor CW and Kirby AM: Cardiac
side-effects from breast cancer radiotherapy. Clin Oncol (R Coll
Radiol). 27:621–629. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Loi S, Haibe-Kains B, Desmedt C, Wirapati
P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF, et
al: Predicting prognosis using molecular profiling in estrogen
receptor-positive breast cancer treated with tamoxifen. BMC
Genomics. 9:2392008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mohapatro SK, Dandapat MC and Padhi NC:
Toxicity and side-effects of combination chemohormonal therapy of
advanced breast cancer. J Indian Med Assoc. 90:39–42.
1992.PubMed/NCBI
|
|
9
|
Dixon JM: Endocrine resistance in breast
cancer. New J Sci. 1–27. 2014. View Article : Google Scholar
|
|
10
|
Hudis CA and Gianni L: Triple-negative
breast cancer: An unmet medical need. Oncologist. 1 Suppl
16:S1–S11. 2011. View Article : Google Scholar
|
|
11
|
Patel K, Singh GK and Patel DK: A review
on pharmacological and analytical aspects of naringenin. Chin J
Integr Med. 24:551–560. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Azuma T, Shigeshiro M, Kodama M, Tanabe S
and Suzuki T: Supplemental naringenin prevents intestinal barrier
defects and inflammation in colitic mice. J Nutr. 143:827–834.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sasaki K, Tsuno NH, Sunami E, Tsurita G,
Kawai K, Okaji Y, Nishikawa T, Shuno Y, Hongo K, Hiyoshi M, et al:
Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on
colon cancer cells. BMC Cancer. 10:3702010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ziegler RG, Anderson WF and Gail MH:
Increasing breast cancer incidence in China: The numbers add up. J
Natl Cancer Inst. 100:1339–1341. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hong W and Dong E: The past, present and
future of breast cancer research in China. Cancer Lett. 351:1–5.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu ZG, Jia CX, Geng CZ, Tang JH, Zhang J
and Liu LY: Risk factors related to female breast cancer in regions
of northeast china: A 1:3 matched case-control population-based
study. Chin Med J (Engl). 125:733–740. 2012.PubMed/NCBI
|
|
17
|
McPherson K, Steel CM and Dixon JM: Breast
cancer-epidemiology, risk factors, and genetics. BMJ. 321:624–628.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stuckey A: Breast cancer: Epidemiology and
risk factors. Clin Obstet Gynecol. 54:96–102. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nikoletopoulou V, Markaki M, Palikaras K
and Tavernarakis N: Crosstalk between apoptosis, necrosis and
autophagy. Biochim Biophys Acta. 1833:3448–3459. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miao P, Sheng S, Sun X, Liu J and Huang G:
Lactate dehydrogenase a in cancer: A promising target for diagnosis
and therapy. IUBMB Life. 65:904–910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Crowley LC, Christensen ME and Waterhouse
NJ: Measuring survival of adherent cells with the Colony-forming
assay. Cold Spring Harb Protoc. 2016:721–724. 2016. View Article : Google Scholar
|
|
22
|
Wong RS: Apoptosis in cancer: From
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Johnstone RW, Ruefli AA and Lowe SW:
Apoptosis: A link between cancer genetics and chemotherapy. Cell.
108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kerr JF, Winterford CM and Harmon BV:
Apoptosis. Its significance in cancer and cancer therapy. Cancer.
73:2013–2026. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reed JC: Apoptosis-targeted therapies for
cancer. Cancer Cell. 3:17–22. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Han X, Ren D, Fan P, Shen T and Lou H:
Protective effects of naringenin-7-O-glucoside on
doxorubicin-induced apoptosis in H9C2 cells. Eur J Pharmacol.
581:47–53. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arul D and Subramanian P: Naringenin
(citrus flavonone) induces growth inhibition, cell cycle arrest and
apoptosis in human hepatocellular carcinoma cells. Pathol Oncol
Res. 19:763–770. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park HJ, Choi YJ, Lee JH and Nam MJ:
Naringenin causes ASK1-induced apoptosis via reactive oxygen
species in human pancreatic cancer cells. Food Chem Toxicol.
99:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fiandalo MV and Kyprianou N: Caspase
control: Protagonists of cancer cell apoptosis. Exp Oncol.
34:165–175. 2012.PubMed/NCBI
|
|
30
|
Olsson M and Zhivotovsky B: Caspases and
cancer. Cell Death Differ. 18:1441–1449. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Salvesen GS and Dixit VM: Caspases:
Intracellular signaling by proteolysis. Cell. 91:443–446. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hensley P, Mishra M and Kyprianou N:
Targeting caspases in cancer therapeutics. Biol Chem. 394:831–843.
2013. View Article : Google Scholar : PubMed/NCBI
|
